Effect of different PD-1 inhibitor combination therapies for unresectable intrahepatic cholangiocarcinoma.

Alimentary pharmacology & therapeutics(2023)

Cited 5|Views35
No score
Abstract
Among patients with uICC, ICI-chemo or ICI-target provided more survival benefits than Chemo while achieving comparable prognoses and fewer adverse events than ICI-target-chemo.
More
Translated text
Key words
chemotherapy, combination therapy, immune checkpoint inhibitor, immunotherapy, intrahepatic cholangiocarcinoma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined